Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.1353
-0.0040 (-2.87%)
At close: Aug 17, 2026, 4:00 PM EDT
0.1357
+0.0004 (0.30%)
After-hours: Aug 17, 2026, 8:00 PM EDT
Azitra Employees
Azitra had 13 employees as of December 31, 2025. The number of employees increased by 1 or 8.33% compared to the previous year.
Employees
13
Change (1Y)
1
Growth (1Y)
8.33%
Revenue / Employee
n/a
Profits / Employee
-$944,072
Market Cap
2.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 1 | 8.33% |
| Dec 31, 2024 | 12 | 2 | 20.00% |
| Dec 31, 2023 | 10 | 0 | - |
| Mar 31, 2023 | 10 | 0 | - |
| Dec 31, 2022 | 10 | 0 | - |
| Sep 30, 2022 | 10 | 0 | - |
| Dec 31, 2021 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 26 |
| Genprex | 13 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| CDT Equity | 4 |
| GRI Bio | 4 |
| Oragenics | 3 |
AZTR News
- 16 hours ago - Azitra reports Q2 EPS (17c) vs. ($1.18) last year - TheFly
- 5 days ago - Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates - PRNewsWire
- 5 days ago - Azitra Quarterly report: Q2 2026 - Filings
- 5 days ago - Azitra Earnings release: Q2 2026 - Filings
- 19 days ago - Meet Azitra: Fly Exclusive with CEO Francisco Salva - TheFly
- 19 days ago - Azitra building multi market microbial engineering platform, CEO says - TheFly
- 19 days ago - Azitra says Phase 1/2 ATR 04 trial remains on track for topline data this year - TheFly
- 19 days ago - CEO says breadth of Azitra’s platform opens multiple attractive markets - TheFly